Rheology of Complex Topical Formulations: An Analytical Quality by Design Approach to Method Optimization and Validation
Abstract
:1. Introduction
- Definition of the analytical target profile (ATP): type of sample, type of the product, method application, type of analytical method, and instrument desirability;
- Risk assessment performance: made through an Ishikawa diagram and a failure mode, effects, and criticality (FMECA) analysis, in order to clearly define the selection of both CMVs and CAAs;
- Design of experiments (DoE): resorting to a 2k full factorial design to identify the parameters that have a more preponderant role in the method ATP, estimated through the desirability function;
2. Materials and Methods
2.1. Materials
2.2. Methods
2.2.1. Preparation of Clobetasol Propionate Cream Formulations
- (i)
- Formulation F1, considered as the main formulation and also used for DoE studies;
- (ii)
- Formulation F2, containing a different glycerol monostearate content, while formulation variable. This excipient was selected due to its thickening role;
- (iii)
- Formulation F3, which was produced using a different homogenization rate, while process variable. Product development studies revealed that a change in this operational setting highly impacted the rheological characteristics of the product.
2.2.2. Equipment Verification
2.2.3. AQbD Rheology Method Development
Analytical Target Profile
Initial Risk Assessment
Method Optimization
- Rotational measurements
- 2.
- Creep recovery
- 3.
- Oscillatory measurements
Definition of the Optimal Operational Settings
2.2.4. Method Validation
Precision
Selectivity
2.2.5. Statistical Analysis
3. Results and Discussion
3.1. Equipment Verification
3.2. AQbD Rheology Method Development
3.2.1. Definition of ATP
3.2.2. Initial Risk Assessment
- Zero-shear viscosity is the limiting value of the shear rate-dependent viscosity function at an “infinitely low” shear rate, meaning the first Newtonian range with the plateau value;
- Infinite-shear viscosity is the limiting value of the shear rate-dependent viscosity function at an “infinitely high” shear rate, meaning the last Newtonian range with the plateau value;
- Yield point (also called yield stress) is the lowest shear stress value above which a material behaves as a fluid, and below which the material acts as a solid; in other words, it is the minimum shear stress required to initiate flow [59].
- Linear viscoelastic range (LVR region), which indicates the range in which the test can be carried out without destroying the structure of the sample and represents a material’s ability in preserving its microstructure when exposed to rising shear stress;
- Yield point, which stands for the stress value at which the curve begins to deviate noticeably from the LVR plateau or from the corresponding fitted straight line used for analysis;
- Flow point, representing the shear stress value where the moduli cross over (G′ = G″) [41].
3.2.3. Optimization of the Rheological Measurements
Rotational Measurements
Creep Recovery
Oscillatory Measurements
3.2.4. Risk Assessment Update
3.2.5. Optimal Operational Settings
3.3. Method Validation
3.3.1. Precision
3.3.2. Selectivity
3.4. Summing-Up
4. Bridging Compendial Testing with Rheometry-Based Approach
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
AQbD | Analytical Quality by Design |
FMECA | Failure mode, effects, and criticality analysis |
FDA | Food and Drug Administration |
EMA | European Medicines Agency |
DoE | Design of experiments |
CP | Clobetasol propionate |
ATP | Analytical target profile |
QTPP | Quality target product profile |
CQA | Critical quality attribute |
CAA | Critical analytical attribute |
CMV | Critical method variable |
RPN | Risk priority number |
ANOVA | One-way analysis of variance |
o/w | Oil-in-water |
F1 | Clobetasol propionate 0.5 mg/g cream formulation |
F2 | Clobetasol propionate 0.5 mg/g cream formulation manufactured with 5% w/w of glyceryl monostearate amount |
F3 | Clobetasol propionate 0.5 mg/g cream formulation with different manufactured process |
CR | Controlled-rate |
CS | Controlled-stress |
γ | Shear rate |
τ | Shear stress |
Je | Creep compliance |
γe | Elastic reformation |
LVR | Linear viscoelastic region |
G″ | Loss modulus |
G′ | Storage modulus |
RSD | Relative standard deviation |
SR | Thixotropic relative area |
τf | Flow point |
τ0.OSC | Oscillatory yield point |
τ0.ROT | Rotational yield point |
ƞ∞ | Infinite-shear viscosity |
ƞ0 | Zero-shear viscosity |
CP | Cone–plate |
PP | Plate–plate |
References
- Folzer, E.; Gonzalez, D.; Singh, R.; Derendorf, H. Comparison of Skin Permeability for Three Diclofenac Topical Formulations: An in Vitro Study. Pharmazie 2014, 69, 27–31. [Google Scholar] [CrossRef]
- Lee, C.H.; Moturi, V.; Lee, Y. Thixotropic Property in Pharmaceutical Formulations. J. Control. Release 2009, 136, 88–98. [Google Scholar] [CrossRef]
- Brites, G.; Basso, J.; Miranda, M.; Miguel Neves, B.; Vitorino, C.; Cruz, M.T. Development of a New Hydrogel for the Prevention of Allergic Contact Dermatitis. Int. J. Pharm. 2022, 628, 122265. [Google Scholar] [CrossRef]
- SUN, C.C. Materials Science Tetrahedron—A Useful Tool for Pharmaceutical Research and Development. J. Pharm. Sci. 2009, 98, 1671–1687. [Google Scholar] [CrossRef]
- Simões, A.; Veiga, F.; Vitorino, C. Developing Cream Formulations: Renewed Interest in an Old Problem. J. Pharm. Sci. 2019, 108, 3240–3251. [Google Scholar] [CrossRef]
- Kamaruzaman, N.; Yusop, S.M. Determination of Stability of Cosmetic Formulations Incorporated with Water-Soluble Elastin Isolated from Poultry. J. King Saud Univ. Sci. 2021, 33, 101519. [Google Scholar] [CrossRef]
- Kumar, S.; Prasad, M.; Rao, R. Topical Delivery of Clobetasol Propionate Loaded Nanosponge Hydrogel for Effective Treatment of Psoriasis: Formulation, Physicochemical Characterization, Antipsoriatic Potential and Biochemical Estimation. Mater. Sci. Eng. C 2021, 119, 111605. [Google Scholar] [CrossRef]
- Carneiro, S.P. Desenvolvimento e Caracterização de Nanocápsulas de Propionato de Clobetasol Obtidas Por Polimerização in Situ Para Tratamento de Psoríase. Master’s Thesis, Universidade Federal de Ouro Preto, Ouro Preto, Brazil, 2013. [Google Scholar]
- Kasongo, K.W. Development and in Vitro Evaluation of a Clobetasol 17-Propionate Topical Cream Formulation. Master’s Thesis, Faculty of Pharmacy, Rhodes University, Grahamstown, South Africa, 2007. [Google Scholar]
- Jacob, S.E.; Steele, T. Corticosteroid Classes: A Quick Reference Guide Including Patch Test Substances and Cross-Reactivity. J. Am. Acad. Dermatol. 2006, 54, 723–727. [Google Scholar] [CrossRef]
- Marks, J.G.; Elsner, P.; DeLeo, V.A. Contact and Occupational Dermatology; Mosby: New York, NY, USA, 2002; ISBN 9780323014731. [Google Scholar]
- Gordon, M.L. The Role of Clobetasol Propionate Emollient 0.05% in the Treatment of Patients with Dry, Scaly, Corticosteroid-Responsive Dermatoses. Clin. Ther. 1998, 20, 26–39. [Google Scholar] [CrossRef]
- Hajare, A.A.; Velapure, P.D.; Rathod, P.N.; Patil, K.S.; Chopade, S.S. Formulation and Evaluation of Solid Lipid Nanoparticle Gel for Topical Delivery of Clobetasol Propionate To Enhance Its Permeation Using Silk Sericin As Permeation Enhancer. Int. J. Pharm. Sci. Res. 2020, 11, 2356–2365. [Google Scholar] [CrossRef]
- Langley, N.; Michniak-Kohn, B.; Osborne, D.W. The Role of Microstructure in Topical Drug Product Development; Springer: Westlake Village, CA, USA, 2019; ISBN 9783030173548. [Google Scholar]
- Simões, A.; Miranda, M.; Cardoso, C.; Veiga, F.; Vitorino, C. Rheology by Design: A Regulatory Tutorial for Analytical Method Validation. Pharmaceutics 2020, 12, 820. [Google Scholar] [CrossRef]
- aylor, K.; Aulton, M. Aulton Pharmaceutics, The Design and Manufacture of Medicines, 5th ed.Elsevier: Amsterdam, The Netherlands, 2018; ISBN 9780702070051. [Google Scholar]
- J Mastropietro, D. Rheology in Pharmaceutical Formulations-A Perspective. J. Dev. Drugs 2013, 2, 1–7. [Google Scholar] [CrossRef] [Green Version]
- Dabbaghi, M.; Namjoshi, S.; Panchal, B.; Grice, J.E.; Prakash, S.; Roberts, M.S.; Mohammed, Y. Viscoelastic and Deformation Characteristics of Structurally Different Commercial Topical Systems. Pharmaceutics 2021, 13, 1351. [Google Scholar] [CrossRef]
- US Food and Drug Administration Guidance for Industry—Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs. Available online: https://www.fda.gov/media/162471/download (accessed on 4 March 2023).
- Navarro-Pujol, F.; Bulut, S.; Hessman, C.; Karabelas, K.; Nieto, C.; Fernandez-Campos, F. Pilot Equivalence Study Comparing Different Batches of Topical 0.025% Capsaicin Emulsion: Product Microstructure, Release, and Permeation Evaluation. Pharmaceutics 2021, 13, 83. [Google Scholar] [CrossRef]
- Draft Guideline on Quality and Equivalence of Topical Products—CHMP/QWP/708282/2018; European Medicines Agency: London, UK, 2018; pp. 1–36.
- ICH Analytical Procedure Development—ICH (Q14); European Medicines Agency: Amsterdam, The Netherlands, 2022; pp. 1–61.
- Grangeia, H.B.; Silva, C.; Simões, S.P.; Reis, M.S. Quality by Design in Pharmaceutical Manufacturing: A Systematic Review of Current Status, Challenges and Future Perspectives. Eur. J. Pharm. Biopharm. 2020, 147, 19–37. [Google Scholar] [CrossRef]
- Raman, N.V.V.S.S.; Mallu, U.R.; Bapatu, H.R. Analytical Quality by Design Approach to Test Method Development and Validation in Drug Substance Manufacturing. J. Chem. 2015, 2015, 1–8. [Google Scholar] [CrossRef]
- Fukuda, I.M.; Pinto, C.F.F.; Moreira, C.D.S.; Saviano, A.M.; Lourenço, F.R. Design of Experiments (DoE) Applied to Pharmaceutical and Analytical Quality by Design (QbD). Brazilian J. Pharm. Sci. 2018, 54, 1–16. [Google Scholar] [CrossRef]
- Miranda, M.; Cardoso, C.; Vitorino, C. Quality and Equivalence of Topical Products: A Critical Appraisal. Eur. J. Pharm. Sci. 2020, 148, 105082. [Google Scholar] [CrossRef]
- Miranda, M.; Pais, A.A.C.C.; Cardoso, C.; Vitorino, C. AQbD as a Platform for IVRT Method Development—A Regulatory Oriented Approach. Int. J. Pharm. 2019, 572, 118695. [Google Scholar] [CrossRef]
- Verch, T.; Campa, C.; Chéry, C.C.; Frenkel, R.; Graul, T.; Jaya, N.; Nakhle, B.; Springall, J.; Starkey, J.; Wypych, J.; et al. Analytical Quality by Design, Life Cycle Management, and Method Control. AAPS J. 2022, 24, 34. [Google Scholar] [CrossRef]
- Yu, L.X.; Amidon, G.; Khan, M.A.; Hoag, S.W.; Polli, J.; Raju, G.K.; Woodcock, J. Review Article Understanding Pharmaceutical Quality by Design. Am. Assoc. Pharm. Sci. 2014, 16, 771–783. [Google Scholar]
- Pharmaceutical Development—ICH Q8(R2); European Medicines Agency: Amsterdam, The Netherlands, 2009.
- European Medicines Agency Guideline on Quality of Oral Modified Release Products; European Medicines Agency: Amsterdam, The Netherlands, 2014; pp. 1–17.
- Food and Drug Administration Draft Guidance on Acyclovir Cream; Food and Drug Administration: Silver Spring, MD, USA, 2016; pp. 1–26.
- European Medicines Agency Guideline on Quality and Equivalence of Topical Products; European Medicines Agency: Amsterdam, The Netherlands, 2018; pp. 1–36.
- United States Pharmacopeia. Analytical Procedure Lifecycle, General Chapter <1220>; United States Pharmacopeia: Rockville, MD, USA, 2022; pp. 1–18. [Google Scholar]
- Beg, S.; Hasnain, M.S.; Rahman, M.; Almalki, W. Handbook of Analytical Quality by Design, 1st ed.; Elsevier: Chennai, India, 2021; ISBN 978-0-12-820332-3. [Google Scholar]
- Carriço, C.; Pinto, P.; Gonçalves, M.; Ribeiro, H.M.; Marto, J. Design and Characterization of a New Quercus Suber-Based Pickering Emulsion for Topical Application. Pharmaceutics 2019, 11, 131. [Google Scholar] [CrossRef] [Green Version]
- Andrade, C.L.; De La O Herrera, M.A.; Lemes, E.M.B. A Model of Risk Analysis in Analytical Methodology for Biopharmaceutical Quality Control. PDA J. Pharm. Sci. Technol. 2018, 72, 317–331. [Google Scholar] [CrossRef]
- Sumit, K.; Shikha, T.; Deepika, T.; Ashish, B. A Quantitative Approach for Pharmaceutical Quality by Design Patterns. Inventi Rapid: Pharm Anal. Qual. Assur. 2012, 2012, 1–8. [Google Scholar]
- Vukašinović, M.; Savić, S.; Cekić, N.; Ilić, T.; Pantelić, I.; Savić, S.D. Efficient Development of Green Emulsifier/Emollient-Based Emulsion Vehicles: From RSM Optimal Experimental Design to Abridged In Vivo Assessment. Pharmaceutics 2023, 15, 486. [Google Scholar] [CrossRef]
- Quality Risk Management ICH (Q9). Available online: https://www.ema.europa.eu/en/documents/scientific-guideline/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use_en-3.pdf (accessed on 21 January 2023).
- Simões, A.; Veiga, F.; Vitorino, C. Progressing towards the Sustainable Development of Cream Formulations. Pharmaceutics 2020, 12, 647. [Google Scholar] [CrossRef]
- Yamamoto, R.; Onuki, A. Nonlinear Rheology of a Highly Supercooled Liquid. Europhys. Lett. 1997, 40, 61–66. [Google Scholar] [CrossRef] [Green Version]
- Helleloid, G.T. On the Computation of Viscosity-Shear Rate Temperature Master Curves for Polymeric Liquids. Morehead Electron. J. Appl. Math. 2001, 1, 1–11. [Google Scholar]
- Hardt, N.A.; Boom, R.M.; van der Goot, A.J. Wheat Dough Rheology at Low Water Contents and the Influence of Xylanases. Food Res. Int. 2014, 66, 478–484. [Google Scholar] [CrossRef]
- Menard, K.P.; Menard, N.R. Rheology Basic: Creep-Recovery and Stress Relaxation. In Dynamic Mechanical Analysis; CRC Press: Boca Raton, FL, USA, 2020; pp. 45–68. [Google Scholar]
- Figueroa, J.D.C.; Hernández, Z.J.E.; Rayas-Duarte, P.; Peña, R.J. Stress Relaxation and Creep Recovery Tests Performed on Wheat Kernels versus Doughs: Influence of Glutenins on Rheological and Quality Properties. Cereal Foods World 2013, 58, 139–144. [Google Scholar] [CrossRef] [Green Version]
- Schramm, G. A Practical Approach to Rheology and Rheometer, 2nd ed.; Thermo Electron (Karlsruhe): Karlsruhe, Germany, 2004. [Google Scholar]
- Kochling, J.; Wu, W.; Hua, Y.; Guan, Q.; Castaneda-Merced, J. A Platform Analytical Quality by Design (AQbD) Approach for Multiple UHPLC-UV and UHPLC-MS Methods Development for Protein Analysis. J. Pharm. Biomed. Anal. 2016, 125, 130–139. [Google Scholar] [CrossRef]
- Harmonisation, I.C. ICH Guideline Q2(R2) on Validation of Analytical Procedures. Available online: https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-q2r2-validation-analytical-procedures-step-2b_en.pdf (accessed on 20 January 2023).
- Food and Drug Administration—FDA Bioanalytical Method Validation—Guidance for Industry. Available online: https://www.fda.gov/files/drugs/published/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf (accessed on 5 February 2023).
- Rath, S.; Kanfer, I. A Validated IVRT Method to Assess Topical Creams Containing Metronidazole Using a Novel Approach. Pharmaceutics 2020, 12, 119. [Google Scholar] [CrossRef] [Green Version]
- Ueda, C.T.; Shah, V.P.; Derdzinski, K.; Ewing, G.; Flynn, G.; Maibach, H.; Marques, M.R.C.; Rytting, H.J.; Shaw, S.; Thakker, K.; et al. Topical and Transdermal Drug Products. Pharmacop. Forum 2009, 35, 750–764. [Google Scholar] [CrossRef]
- Varzakas, T. HACCP and ISO22000: Risk Assessment in Conjunction with Other Food Safety Tools Such as FMEA, Ishikawa Diagrams and Pareto. In Encyclopedia of Food and Health; Elsevier: Kalamata, Germany, 2015; pp. 295–302. ISBN 9780123849533. [Google Scholar]
- Pinthong, T.; Yooyod, M.; Daengmankhong, J.; Tuancharoensri, N.; Mahasaranon, S.; Viyoch, J.; Jongjitwimol, J.; Ross, S.; Ross, G.M. Development of Natural Active Agent-Containing Porous Hydrogel Sheets with High Water Content for Wound Dressings. Gels 2023, 9, 459. [Google Scholar] [CrossRef]
- Radhouani, H.; Gonçalves, C.; Maia, F.R.; Oliveira, E.P.; Reis, R.L.; Oliveira, J.M. Development of Conjugated Kefiran-Chondroitin Sulphate Cryogels with Enhanced Properties for Biomedical Applications. Pharmaceutics 2023, 15, 1662. [Google Scholar] [CrossRef]
- Wang, X.; Rong, L.; Shen, M.; Yu, Q.; Chen, Y.; Li, J.; Xie, J. Rheology, Texture and Swallowing Characteristics of a Texture-Modified Dysphagia Food Prepared Using Common Supplementary Materials. Foods 2023, 12, 2287. [Google Scholar] [CrossRef]
- Evans, P.E. Failure Mode Effects and Criticality Analysis. Conf. Rec. Midcon 1987, 11, 168–171. [Google Scholar] [CrossRef]
- Ford Motor Company Failure Mode and Effects Analysis, FMEA Handbook (with Robustness Linkages). Ford Mot. Co. 2011, 13, 286.
- Mezger, T.G. The Rheology Handbook, 4th ed.; Vincentz Network: Hanover, Germany, 2014; ISBN 9783866306509. [Google Scholar]
- Pisal, P.B.; Patil, S.S.; Pokharkar, V.B. Rheological Investigation and Its Correlation with Permeability Coefficient of Drug Loaded Carbopol Gel: Influence of Absorption Enhancers. Drug Dev. Ind. Pharm. 2013, 39, 593–599. [Google Scholar] [CrossRef]
- Talens, P.; Castells, M.L.; Verdú, S.; Barat, J.M.; Grau, R. Flow, Viscoelastic and Masticatory Properties of Tailor Made Thickened Pea Cream for People with Swallowing Problems. J. Food Eng. 2021, 292, 110265. [Google Scholar] [CrossRef]
- Karaman, S.; Yilmaz, M.T.; Cankurt, H.; Kayacier, A.; Sagdic, O. Linear Creep and Recovery Analysis of Ketchup-Processed Cheese Mixtures Using Mechanical Simulation Models as a Function of Temperature and Concentration. Food Res. Int. 2012, 48, 507–519. [Google Scholar] [CrossRef]
- Maurya, C.S.; Sarkar, C. Rheological and Creep and Recovery Behavior of Carbonyl Iron Water-Based Magnetorheological Gel Using Laponite as an Additive and Oleic Acid as a Surfactant. Rheol. Acta 2022, 61, 99–110. [Google Scholar] [CrossRef]
- Vitorino, C.; Carvalho, F.A.; Almeida, A.J.; Sousa, J.J.; Pais, A.A.C.C. The Size of Solid Lipid Nanoparticles: An Interpretation from Experimental Design. Colloids Surf. B Biointerfaces 2011, 84, 117–130. [Google Scholar] [CrossRef]
- Vitorino, C.; Silva, S.; Gouveia, F.; Bicker, J.; Falcão, A.; Fortuna, A. QbD-Driven Development of Intranasal Lipid Nanoparticles for Depression Treatment. Eur. J. Pharm. Biopharm. 2020, 153, 106–120. [Google Scholar] [CrossRef]
- Herh, P.; Tkachuk, J.; Wu, S.; Bernzen, M.; Rudolph, B. Rheology of Pharmaceutical and Cosmetic Semisolids. Am. Lab. 1998, 30, 12–14. [Google Scholar]
- Salas-Bringas, C. Development and Verification of Methods for the Rheological Characterization of Materials for the Process Industry. Ph.D. Thesis, Norwegian University of Life Sciences, Ås, Norway, 2011. [Google Scholar]
- Stokes, J.R.; Telford, J.H. Measuring the Yield Behaviour of Structured Fluids. J. Nonnewton. Fluid Mech. 2004, 124, 137–146. [Google Scholar] [CrossRef]
- Dakhil, H.; Auhl, D.; Wierschem, A. Infinite-Shear Viscosity Plateau of Salt-Free Aqueous Xanthan Solutions. J. Rheol. 2019, 63, 63–69. [Google Scholar] [CrossRef]
- Instruments, M. A Basic Introduction to Rheology. Available online: https://cdn.technologynetworks.com/TN/Resources/PDF/WP160620BasicIntroRheology.pdf (accessed on 2 March 2023).
- Escudier, M.P.; Gouldson, I.W.; Pereira, A.S.; Pinho, F.T.; Poole, R.J. On the Reproducibility of the Rheology of Shear-Thinning Liquids. J. Nonnewton. Fluid Mech. 2001, 97, 99–124. [Google Scholar] [CrossRef]
- Chen, T. Rheological Techniques for Yield Stress Analysis. Available online: https://www.tainstruments.com/pdf/literature/RH025.pdf (accessed on 2 March 2023).
- Viscosity Testing Lab—The Centre for Industrial Rheology. Available online: https://www.rheologylab.com/services/viscosity-testing-lab/?campaign=15568012273&content=569564286655&keyword=viscosity%20measurements&gclid=Cj0KCQjw8qmhBhClARIsANAtbodGDikwos4vK5Pcned5OrWd3uXRL14PktKOinE9SM0yr66E9-f8y78aAmJ4EALw_wcB (accessed on 3 April 2023).
- Reid, E. Rheology Model Fitting and Corrections. Available online: https://blog.rheosense.com/rheology-model-fitting-and-corrections (accessed on 3 March 2023).
- Stanciu, I.; Ouerfelli, N. An Extended Casson Equation for Rheological Properties of Soybean Oil at Different Temperatures and Atmospheric Pressure. J Biochem Tech 2020, 11, 52–57. [Google Scholar]
- Mukhopadhyay, S.; De, P.R.; Bhattacharyya, K.; Layek, G.C. Casson Fluid Flow over an Unsteady Stretching Surface. Ain Shams Eng. J. 2013, 4, 933–938. [Google Scholar] [CrossRef] [Green Version]
- TA Instruments Rheology Aplications Note: Rheology Software Models (Flow). Available online: http://www.tainstruments.com/pdf/literature/RN9.pdf (accessed on 4 March 2023).
- Meyer, F. Investigating the Thixotropic and Shear Recovery Behaviour of Paints and Coatings. PPCJ Polym. Paint Colour J. 2014, 204, 26–29. [Google Scholar]
- Liu, J.; Wang, R.; Gao, F.; Zhou, J.; Cen, K. Rheology and Thixotropic Properties of Slurry Fuel Prepared Using Municipal Wastewater Sludge and Coal. Chem. Eng. Sci. 2012, 76, 1–8. [Google Scholar] [CrossRef]
- Daver, F.; Kajtaz, M.; Brandt, M.; Shanks, R.A. Creep and Recovery Behaviour of Polyolefin-Rubber Nanocomposites Developed for Additive Manufacturing. Polymers 2016, 8, 437. [Google Scholar] [CrossRef] [Green Version]
- Netzsch Creep (Rheology). Available online: https://analyzing-testing.netzsch.com/en/training-know-how/glossary/creep-rheology (accessed on 20 April 2023).
- Rheologylab Creep Test for Liquids and Semisolids. Available online: https://www.rheologylab.com/articles/creep-test/ (accessed on 20 April 2023).
- Van Vliet, T.; Lyklema, H. Rheology. Fundam. Interface Colloid Sci. 2005, 4, 1–14. [Google Scholar]
- Suñer-Carbó, J.; Calpena-Campmany, A.; Halbaut-Bellowa, L.; Clares-Naveros, B.; Rodriguez-Lagunas, M.J.; Barbolini, E.; Zamarbide-Losada, J.; Boix-Montañés, A. Biopharmaceutical Development of a Bifonazole Multiple Emulsion for Enhanced Epidermal Delivery. Pharmaceutics 2019, 11, 66. [Google Scholar] [CrossRef] [Green Version]
- Petit, J.Y.; Wirquin, E.; Khayat, K.H. Effect of Temperature on the Rheology of Flowable Mortars. Cem. Concr. Compos. 2010, 32, 43–53. [Google Scholar] [CrossRef]
- Budai, L.; Budai, M.; Fülöpné Pápay, Z.E.; Vilimi, Z.; Antal, I. Rheological Considerations of Pharmaceutical Formulations: Focus on Viscoelasticity. Gels 2023, 9, 469. [Google Scholar] [CrossRef]
- Stojkov, G.; Niyazov, Z.; Picchioni, F.; Bose, R.K. Relationship between Structure and Rheology of Hydrogels for Various Applications. Gels 2021, 7, 255. [Google Scholar] [CrossRef]
- Rheological Analysis of Dispersions by Frequency Sweep Testing. Available online: https://www.azom.com/article.aspx?ArticleID=2884# (accessed on 27 April 2023).
- Mcgregor, P.L.; Hong, P.; Pham, T. Mitigating Risk of Validated Analytical Procedure Failures When Upgrading or Replacing LC Assets: Harnessing the Power of Quality by Design (QbD) Principles; Waters Corporation: Milford, MA, USA, 2021; pp. 1–10. [Google Scholar]
- Life Cycle Risk Assessment of HPLC Instruments. Available online: https://www.chromatographyonline.com/view/life-cycle-risk-assessment-hplc-instruments (accessed on 3 May 2023).
- Bonfilio, R.; Cazedey, E.C.L.; de Araújo, M.B.; Salgado, H.R.N. Analytical Validation of Quantitative High-Performance Liquid Chromatographic Methods in Pharmaceutical Analysis: A Practical Approach. Crit. Rev. Anal. Chem. 2012, 42, 87–100. [Google Scholar] [CrossRef]
- A Guide to Control Charts. Available online: https://www.isixsigma.com/control-charts/a-guide-to-control-charts/ (accessed on 27 April 2023).
Components | Function |
---|---|
Clobetasol propionate | Active pharmaceutical ingredient |
Chlorocresol | Preservative |
Glyceryl monostearate | Emulsifying agent, emollient |
Cetostearyl alcohol | Emulsifying agent, emollient |
Citric acid | pH regulator |
Sodium citrate | pH regulator |
Propylene glycol | Co-solvent |
Beeswax | Stabilizer agent |
Purified water | Solvent |
Formulation | Description | Studies Used |
---|---|---|
F1 | Glycerol monostearate: nominal % Homogenization rate: nominal speed | DoE/Method validation: Precision |
F2 | Glycerol monostearate: lower % Homogenization rate: nominal speed | Method validation: Selectivity |
F3 | Glycerol monostearate: nominal % Homogenization rate: lower speed | Method validation: Selectivity |
Temperature | Viscosity η (Pa·s−1) |
---|---|
Standard 25 °C | Mean = 12.50 RSD = 6.36% |
Standard 32 °C | Mean = 11.55 RSD = 6.29% |
ATP Element | Target/Objective (s) | Justification | Specification | |
---|---|---|---|---|
Sample type (What/Where should be measured?) | Semisolid complex dosage forms: o/w cream formulations | Development of an analytical method that seeks to characterize the rheological behavior of a semisolid complex pharmaceutical dosage form. | N.A. | |
Product type (When should it be measured?) | Product development stages; Stability studies; Marketed products | The pharmaceutical product must display a viscosity profile that conforms to skin application. | N.A. | |
Method application | Characterization of a semisolid dosage form and validation of the developed method | The rheological properties such as viscosity and thixotropy of semisolid dosage forms need to be inspected, as they may influence drug delivery as well as impact patient adherence to treatment. | N.A. | |
Analytical method | Rheological analysis | Taking into account regulatory recommendations, the rheology analysis should comprehend the rotational profile (a complete flow curve, thixotropic relative area), creep test, as well as the oscillatory profile (frequency sweep and amplitude sweep) measurements. | N.A. | |
Equipment | Rotational rheometer equipped with a peltier system as a temperature control unit | A rheometer shears the sample between an upper rotating cone/plate and a lower fixed plate. The shear stress applied comes directly from the torque. The induced shear promotes the formation of horizontal layers of the sample. Due to this configuration, the rheometer requires a small amount of sample, and at the same time, it enables a rigorous control of the applied shear rate. From the rheological analysis, it is possible to retrieve a vast range of rheology endpoints. The temperature of the rheological tests needs to be controlled; furthermore, the minimization of sample volatilization during the analysis should also be actively pursued. | N.A. | |
Rheology critical analytical attributes (CAAs) | Zero-shear viscosity (η0, Pa·s−1); Infinite-shear viscosity (η∞, Pa·s−1); Yield point (τ0.ROT, Pa); Relative thixotropic area (SR, Pa·s); Creep equilibrium compliance (Je, Pa−1); Response elastic reformation (γe, %); LVR plateau (LVR, Pa); Yield point (τ0.OSC, Pa); Flow point (τf, Pa); Storage modulus (G′, Pa); Loss modulus (G″, Pa). | The relevance of each CAA is detailed in the following sections. | These CAAs should reflect the maximization of the rheology profile, except for the SR where a more rapid recuperation of the formulation structure aimed to lower SR. | |
Method validation parameters | Discriminatory power Selectivity | Capacity of the method to distinguish between different formulations | A solid documentation of method discriminatory ability is progressively being demanded by regulatory authorities. | Selectivity: The differences between formulations should be statistically significant (ANOVA and Tukey test). |
Precision | Capacity to reproduce the operation over a short period of time | Degree of agreement among individual test results when an analytical method is used repeatedly on multiple samplings of a homogeneous sample. | An RSD less than 15% is considered acceptable from the mean CAAs [50]. |
Score | Criteria | |
---|---|---|
Severity (S) | 1 (very low) | No impact to method quality |
2 (low) | No impact to method quality | |
3 (average) | Noticeable impact to method quality, but can be recovered by reprocessing | |
4 (high) | Definite impact to method quality that may require attention | |
5 (very high) | Very severe effect, requires particular attention | |
Occurrence (O) | 1 (unlikely) | Negligible risk which does not require attention |
2 (remote) | Failure only seen once or twice | |
3 (occasional) | Failure potential has been noted | |
4 (moderate) | Moderate-probability occurrence | |
5 (likely) | Highly severe effect which requires utmost attention | |
Detection (D) | 1 (very low) | Easily detectable; negligible risk which does not require attention |
2 (low) | Good detectability: possesses minor risk which can be corrected | |
3 (average) | Detectable; risk which can be corrected | |
4 (high) | Not easily detectable; risk requires attention | |
5 (very high) | Very difficult to detect; risk which requires immediate attention |
Test | Response (CAAs) |
---|---|
Viscosity curve | Zero-shear viscosity (η0, Pa·s) Infinite-shear viscosity (η∞, Pa·s) Yield point (τ0.ROT, Pa) |
Thixotropy | Relative thixotropic area (SR, Pa·s) |
Creep recovery | Creep equilibrium compliance (Je, Pa−1); Response elastic reformation (γe, %) |
Amplitude sweep | LVR plateau (LVR, Pa) Yield point (τ0.OSC, Pa) Flow point (τf, Pa) |
Frequency sweep | Storage modulus (G′, Pa) Loss modulus (G″, Pa) |
Failure Mode | Failure Cause | Failure Effect | Severity | Occurrence | Detection | RPN Score | Recommended Action (s) |
---|---|---|---|---|---|---|---|
CP geometry | Failure to choose geometry | The shear rate is not constant over the whole radius in the measuring gap | 4 | 3 | 3 | 36 | PP geometry can be employed. Effective shear rate varies across a parallel plate. |
PP geometry | Viscosity values contain an intrinsic error | 4 | 3 | 3 | 36 | CP geometry can be employed. The diameter of the geometry has to be chosen in relation to the sample’s viscosity. | |
Sample application | Skills and training of the analyst | Sample should be carefully placed in plate | 5 | 5 | 3 | 75 | Standardize sample application. i.e., apply directly with a syringe or spatula in plate. |
Sample amount | Do not apply the sample at the center of the plate | Under-filled sample can cause lower torque contribution; Over-filled sample can cause additional stress from drag along the edges | 4 | 3 | 3 | 36 | Standardize the quantity of the sample. |
Sample rest time | Lack of scientific knowledge | Absence in sample rest time | 5 | 4 | 3 | 60 | Standardize when to start the analysis, after sample application. |
Gap | Lack of equipment specifications knowledge | As gap height decreases, shear rate increases. Small gaps give high shear rates | 5 | 3 | 3 | 45 | Choose a suitable measuring gap. |
Zero gap | Any error of the zero gap will automatically lead to an increased error of the test results due to a wrong gap size during the test | 2 | 3 | 1 | 6 | Zero gap should always be employed when the geometry is removed. Furthermore, to avoid any error due to thermal expansion, the zero gap has to be determined at the method’s working temperature. | |
Peltier temperature | Lack of scientific knowledge | Viscosity and other rheological parameters strongly depend on temperature | 5 | 5 | 5 | 125 | A system with peltier plate temperature should be employed. |
Factors (CMVs) | Role | Levels | |
---|---|---|---|
Sample application mode | Categorical | Syringe (−) | Spatula (+) |
Peltier temperature control (°C) | Continuous | 25 (−) | 32 (+) |
Sample rest time (min) | Continuous | 0 (−) | 30 (+) |
Experiment | Peltier Temperature Control (°C) | Sample Rest Time (min) | Sample Application Mode |
---|---|---|---|
1 | 25 | 0 | Spatula |
2 | 25 | 0 | Syringe |
3 | 25 | 30 | Spatula |
4 | 25 | 30 | Syringe |
5 | 32 | 0 | Spatula |
6 | 32 | 0 | Syringe |
7 | 32 | 30 | Spatula |
8 | 32 | 30 | Syringe |
Rheological Model | Rheology Equation | Estimated Parameters | R2 Values |
---|---|---|---|
Bingham | ηρ: plastic viscosity; τ0: yield stress. | 0.4572 | |
Cross | η0: zero-shear viscosity; η∞: infinite-shear viscosity; ẏ and n: fluid-specific parameters. | 0.9321 | |
Herschel–Buckley | τ0: yield stress; k: consistency factor; n: flow index. | 0.9534 | |
Ostwald–de Waele | η: viscosity (Pa·s−1); k: flow coefficient; n: flow index. | 0.8286 | |
Casson | τ0: Casson yield point; ηρ: Casson viscosity. | 0.6213 |
Failure Mode | Failure Cause | Failure Effect | Severity | Occurrence | Detection | RPN * Score | Recommended Action (s) |
---|---|---|---|---|---|---|---|
CP geometry | Failure to choose geometry | The shear rate is not constant over the whole radius in the measuring gap | 3 | 2 | 1 | 6 | PP geometry can be employed. Effective shear rate varies across a parallel plate. |
PP geometry | Viscosity values contain an intrinsic error | 3 | 2 | 1 | 6 | CP geometry can be employed. The diameter of the geometry has to be chosen in relation to the sample’s viscosity. | |
Sample application | Skills and training of the analyst | Sample should be carefully placed in plate | 5 | 3 | 3 | 45 | Standardize the sample application. directly apply the sample with the syringe or spatula in plate. |
Sample amount | Do not apply the sample at the center of the plate | Under-filled sample can cause lower torque contribution; Over-filled sample can cause additional stress from drag along the edges | 1 | 2 | 3 | 6 | Standardize the sample quantity. |
Sample rest time | Lack of scientific knowledge | Absence in sample rest time | 5 | 3 | 3 | 45 | Standardize when starting the analysis, after the sample application in plate. |
Gap | Lack of equipment specifications knowledge | As gap height decreases, shear rate increases. Small gaps give high shear rates | 3 | 1 | 1 | 3 | Choose a suitable measuring gap. |
Zero gap | Any error of the zero gap will automatically lead to an increased error of the test results due to a wrong gap size during the test | 2 | 3 | 1 | 6 | Zero gap should always be employed when the geometry is removed. Furthermore, to avoid any error due the thermal expansion, the zero gap has to be determined at the method’s working temperature. | |
Peltier temperature | Lack of scientific knowledge | Viscosity and other rheological parameters strongly depend on temperature | 5 | 3 | 3 | 45 | A system with peltier plate temperature could be employed. |
CAAs | Peltier Temperature Control (°C) | Sample Application | Sample Rest Time (min) | Desirability (D) | ||
---|---|---|---|---|---|---|
Syringe | Spatula | 0 | 30 | |||
Zero-shear viscosity (η0—Pas·s); Infinite-shear viscosity (η∞—Pa.s); Yield point (τ0.ROT—Pa) | 25 | X | X | 0.3328 | ||
32 | X | X | 0.5014 | |||
Relative thixotropic area (SR—Pa·s) | 25 | X | X | 0.3356 | ||
32 | X | X | 0.8683 | |||
Equilibrium compliance (Je, Pa−1); Elastic reformation (γe, %) | 25 | X | X | 0.1508 | ||
32 | X | X | 0.8014 | |||
Viscoelastic region LVR plateau (LVR—Pa); Yield point (τ0.OSC—Pa); Flow stress, flow point (τf—Pa) | 25 | X | X | 0.6809 | ||
32 | X | X | 0.47175 | |||
Storage modulus (G′—Pa); Loss modulus (G″—Pa) | 25 | X | X | 0.8335 | ||
32 | X | X | 0.3425 |
CAAs | Repeatability | Intermediate Precision | ||
---|---|---|---|---|
Mean ± SEM | RSD (%) | Mean ± SEM | RSD (%) | |
Zero-shear viscosity (η0—Pas.s) | 37,246 ± 1027 | 9.55 | 38,181 ± 870 | 11.16 |
Infinite-shear viscosity (η∞—Pa.s) | 15.2 ± 0.5 | 9.01 | 15.5 ± 0.4 | 11.65 |
Yield point (τ0.ROT—Pa) | 369 ± 11 | 10.33 | 382 ± 10 | 13.24 |
Relative thixotropic area (SR—Pa/s) | 76,863 ± 3143 | 14.16 | 76,886 ± 2117 | 13.49 |
Equilibrium compliance (Je—Pa−1) | 0.00105 ± 2.96−5 | 9.75 | 0.00108 ± 2.19−5 | 9.91 |
Elastic reformation (γe—%) | 5.3 ± 0.1 | 9.77 | 5.4 ± 0.1 | 9.92 |
Viscoelastic region LVR plateau (LVR—Pa) | 17,906 ± 723 | 13.99 | 17,114 ± 455 | 13.02 |
Yield point (τ0.OSC—Pa) | 446 ± 10 | 7.97 | 441 ± 7 | 7.27 |
Flow stress, flow point (τf—Pa) | 897 ± 30 | 11.53 | 888 ± 19 | 10.38 |
Storage modulus (G′—Pa) | 21,980 ± 491 | 7.73 | 22,269 ± 415 | 9.14 |
Loss modulus (G″—Pa) | 11,403 ± 205 | 6.22 | 11,384 ± 148 | 6.36 |
CAAs | Formulations | ||
---|---|---|---|
F1 vs. F2 | F1 vs. F3 | F2 vs. F3 | |
Zero-shear viscosity (η0—Pas·s) | Normal distribution? Yes Cl: [26,083 to 30,441] p-value: <0.0001 | Normal distribution? Yes Cl: [25,993 to 30,352] p-value: <0.0001 | Normal distribution? No Cl: [−2269 to 2090] p-value: 0.9944 |
Infinite-shear viscosity (η∞—Pa·s) | Normal distribution? Yes Cl: [1.072 to 4.428] p-value: 0.0009 | Normal distribution? Yes Cl: [−7.812 to −4.457] p-value: <0.0001 | Normal distribution? Yes Cl: [−10.56 to −7.207] p-value: <0.0001 |
Yield point (τ0.ROT—Pa) | Normal distribution? Yes Cl: [319.7 to 363.9] p-value: <0.0001 | Normal distribution? Yes Cl: [302.6 to 346.7] p-value: <0.0001 | Normal distribution? No Cl: [−39.22 to 4.948] p-value: 0.1535 |
Relative thixotropic area (SR—Pa·s) | Normal distribution? Yes Cl: [36,245 to 49,711] p-value: <0.0001 | Normal distribution? Yes Cl: [48,161 to 61,627] p-value: <0.0001 | Normal distribution? Yes Cl: [5183 to 18,649] p-value: 0.0004 |
Equilibrium compliance (Je—Pa−1) | Normal distribution? Yes Cl: [−0.001512 to −0.001012] p-value: <0.0001 | Normal distribution? Yes Cl: [−0.002417 to −0.001917] p-value: <0.0001 | Normal distribution? Yes Cl: [−0.001155 to −0.0006548] p-value: <0.0001 |
Elastic reformation (γe—%) | Normal distribution? Yes Cl: [−7.562 to −5.061] p-value: <0.0001 | Normal distribution? Yes Cl: [−12.08 to −9.583] p-value: <0.0001 | Normal distribution? Yes Cl: [−5.773 to −3.272] p-value: <0.0001 |
Viscoelastic region LVR plateau (LVR—Pa) | Normal distribution? Yes Cl: [6761 to 9961] p-value: <0.0001 | Normal distribution? Yes Cl: [4915 to 8115] p-value: <0.0001 | Normal distribution? Yes Cl: [−3446 to 8115] p-value: 0.0209 |
Yield point (τ0.OSC—Pa) | Normal distribution? Yes Cl: [348 to 394] p-value: <0.0001 | Normal distribution? Yes Cl: [305 to 352] p-value: <0.0001 | Normal distribution? Yes Cl: [−66 to 20] p-value: 0.0002 |
Flow stress, flow point (τf—Pa) | Normal distribution? Yes Cl: [604 to 728] p-value: <0.0001 | Normal distribution? Yes Cl: [710 to 835] p-value: <0.0001 | Normal distribution? Yes Cl: [45 to 169] p-value: 0.0005 |
Storage modulus (G′—Pa) | Normal distribution? Yes Cl: [5995 to 8704] p-value: <0.0001 | Normal distribution? Yes Cl: [12,569 to 15,278] p-value: < 0.0001 | Normal distribution? Yes Cl: [5220 to 7929] p-value: <0.0001 |
Loss modulus (G″—Pa) | Normal distribution? Yes Cl: [2427 to 3752] p-value: <0.0001 | Normal distribution? Yes Cl: [6082 to 7407] p-value: <0.0001 | Normal distribution? Yes Cl: [2992 to 4317] p-value: <0.0001 |
CAAs | Acceptance Criteria | Sample 1 | Sample 2 | Sample 3 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Mean ± SD | RSD (%) | Status | Mean ± SD | RSD (%) | Status | Mean ± SD | RSD (%) | Status | ||
Zero-shear viscosity (η0—Pas·s) | 25,398–50,964 | 32,935 ± 4298 | 13.05 | C | 28,060 ± 2208 | 7.87 | C | 30,989 ± 3685 | 11.89 | C |
Infinite-shear viscosity (η∞—Pa·s) | 10–21 | 15 ± 2 | 14.41 | C | 13 ± 2 | 12.37 | C | 16 ± 2 | 12.42 | C |
Yield point (τ0.ROT—Pa) | 230–534 | 327 ± 29 | 8.88 | C | 214 ± 31 | 14.29 | NC | 277 ± 29 | 10.36 | C |
Relative thixotropic area (SR—Pa·s) | 45,773–107,999 | 59,997 ± 7775 | 12.96 | C | 69,210 ± 10,187 | 14.72 | C | 63,375 ± 7459 | 11.77 | C |
Equilibrium compliance (Je—Pa−1) | 0.000762–0.001407 | 0.0011 ± 0.0001 | 12.50 | C | 0.0013 ± 0.0002 | 13.98 | C | 0.0016 ± 0.0002 | 10.47 | NC |
Elastic reformation (γe—%) | 3.72–6.81 | 5.4 ± 0.7 | 12.49 | C | 6.7 ± 0.9 | 13.98 | C | 8.2 ± 0.9 | 10.46 | NC |
Viscoelastic region LVR plateau (LVR—Pa) | 10,427–23,801 | 20,883 ± 1650 | 7.90 | C | 17,492 ± 1793 | 10.25 | C | 18,782 ± 923 | 4.91 | C |
Yield point (τ0.OSC—Pa) | 345–537 | 464 ± 14 | 3.03 | C | 391 ± 34 | 8.69 | C | 455 ± 47 | 10.29 | C |
Flow stress, flow point (τf—Pa) | 612–1164 | 771 ± 89 | 11.52 | C | 543 ± 40 | 7.30 | C | 646 ± 64 | 9.98 | C |
Storage modulus (G′—Pa) | 16,162–28,378 | 22,003 ± 3287 | 14.94 | C | 22,583 ± 1727 | 7.65 | C | 25,257 ± 1620 | 6.41 | C |
Loss modulus (G″—Pa) | 9212–13,556 | 12,883 ± 1065 | 8.26 | C | 14,373 ± 1618 | 11.26 | NC | 15,895 ± 1604 | 10.09 | NC |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Chiarentin, L.; Cardoso, C.; Miranda, M.; Vitorino, C. Rheology of Complex Topical Formulations: An Analytical Quality by Design Approach to Method Optimization and Validation. Pharmaceutics 2023, 15, 1810. https://doi.org/10.3390/pharmaceutics15071810
Chiarentin L, Cardoso C, Miranda M, Vitorino C. Rheology of Complex Topical Formulations: An Analytical Quality by Design Approach to Method Optimization and Validation. Pharmaceutics. 2023; 15(7):1810. https://doi.org/10.3390/pharmaceutics15071810
Chicago/Turabian StyleChiarentin, Lucas, Catarina Cardoso, Margarida Miranda, and Carla Vitorino. 2023. "Rheology of Complex Topical Formulations: An Analytical Quality by Design Approach to Method Optimization and Validation" Pharmaceutics 15, no. 7: 1810. https://doi.org/10.3390/pharmaceutics15071810
APA StyleChiarentin, L., Cardoso, C., Miranda, M., & Vitorino, C. (2023). Rheology of Complex Topical Formulations: An Analytical Quality by Design Approach to Method Optimization and Validation. Pharmaceutics, 15(7), 1810. https://doi.org/10.3390/pharmaceutics15071810